HEPATITIS C DRUGS
TODAY'S HEADLINES
A new drug FDA approved to treat chronic hepatitis C virus infection enters a competitive, lucrative market headed up by Gilead Science's Sovaldi and Harvoni, as well as AbbVie's Viekira Pak. Find out cost |
|
How the US government plans to bring a $29 million Zika vaccine to market very quickly. Read more
|
CONTINUING PHARMACY EDUCATION
This month's CE activity, "The rundown: Management of acute and chronic diarrhea," is open for pharmacists and pharmacy technicians.
The goal of this activity is to review the various risk factors, etiologies, and treatments of diarrhea as well as the pharmacist's role in its management.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More
|
EDITOR'S PICK
Here are the top 6 things to know about the new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis. Read more
|
|
|
